| Candice Joi Hunter, MD | |
|
24 Joliet St, Dyer, IN 46311-1705 | |
| (219) 322-5747 | |
| (219) 864-2282 |
| Full Name | Candice Joi Hunter |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 20 Years |
| Location | 24 Joliet St, Dyer, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790978245 | NPI | - | NPPES |
| 200910620 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 165709 (California) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 01065064A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Porter-starke Services Inc | 1951293554 | 26 |
News Archive
Researchers who analyzed payroll-based staffing data for U.S. nursing homes discovered large daily staffing fluctuations, low weekend staffing and daily staffing levels that often fall well below the expectations of the Centers for Medicare and Medicaid Services, all of which can increase the risk of adverse events for residents.
MabCure Inc., a leading developer of antibody-based technology for the diagnosis and treatment of ovarian, prostate, colorectal and other cancers, has retained the CUNY Center for Advanced Technology (CUNY CAT) to evaluate its monoclonal antibodies against ovarian cancer cells as diagnostic reagents.
One of the largest and longest-running efforts to evaluate the potential benefits of the Mediterranean-style diet in lowering risk of stroke found that the diet may be especially protective in women over 40 regardless of menopausal status or hormone replacement therapy, according to new research in the American Heart Association's journal Stroke.
Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp, announced today it has received U.S. Food and Drug Administration (FDA) clearance to market Zargis Acoustic Cardioscan (Cardioscan), the first and only computer-aided medical device to support physicians in analyzing heart sounds for the identification of suspected murmurs, a potential sign of heart disease.
› Verified 2 days ago
| Entity Name | Porter-starke Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689627598 PECOS PAC ID: 1951293554 Enrollment ID: O20040330000098 |
News Archive
Researchers who analyzed payroll-based staffing data for U.S. nursing homes discovered large daily staffing fluctuations, low weekend staffing and daily staffing levels that often fall well below the expectations of the Centers for Medicare and Medicaid Services, all of which can increase the risk of adverse events for residents.
MabCure Inc., a leading developer of antibody-based technology for the diagnosis and treatment of ovarian, prostate, colorectal and other cancers, has retained the CUNY Center for Advanced Technology (CUNY CAT) to evaluate its monoclonal antibodies against ovarian cancer cells as diagnostic reagents.
One of the largest and longest-running efforts to evaluate the potential benefits of the Mediterranean-style diet in lowering risk of stroke found that the diet may be especially protective in women over 40 regardless of menopausal status or hormone replacement therapy, according to new research in the American Heart Association's journal Stroke.
Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp, announced today it has received U.S. Food and Drug Administration (FDA) clearance to market Zargis Acoustic Cardioscan (Cardioscan), the first and only computer-aided medical device to support physicians in analyzing heart sounds for the identification of suspected murmurs, a potential sign of heart disease.
› Verified 2 days ago
| Entity Name | Aspire Indiana Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124016050 PECOS PAC ID: 4486635455 Enrollment ID: O20041015000190 |
News Archive
Researchers who analyzed payroll-based staffing data for U.S. nursing homes discovered large daily staffing fluctuations, low weekend staffing and daily staffing levels that often fall well below the expectations of the Centers for Medicare and Medicaid Services, all of which can increase the risk of adverse events for residents.
MabCure Inc., a leading developer of antibody-based technology for the diagnosis and treatment of ovarian, prostate, colorectal and other cancers, has retained the CUNY Center for Advanced Technology (CUNY CAT) to evaluate its monoclonal antibodies against ovarian cancer cells as diagnostic reagents.
One of the largest and longest-running efforts to evaluate the potential benefits of the Mediterranean-style diet in lowering risk of stroke found that the diet may be especially protective in women over 40 regardless of menopausal status or hormone replacement therapy, according to new research in the American Heart Association's journal Stroke.
Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp, announced today it has received U.S. Food and Drug Administration (FDA) clearance to market Zargis Acoustic Cardioscan (Cardioscan), the first and only computer-aided medical device to support physicians in analyzing heart sounds for the identification of suspected murmurs, a potential sign of heart disease.
› Verified 2 days ago
| Entity Name | Aspire Indiana Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780068288 PECOS PAC ID: 8921314196 Enrollment ID: O20150902001749 |
News Archive
Researchers who analyzed payroll-based staffing data for U.S. nursing homes discovered large daily staffing fluctuations, low weekend staffing and daily staffing levels that often fall well below the expectations of the Centers for Medicare and Medicaid Services, all of which can increase the risk of adverse events for residents.
MabCure Inc., a leading developer of antibody-based technology for the diagnosis and treatment of ovarian, prostate, colorectal and other cancers, has retained the CUNY Center for Advanced Technology (CUNY CAT) to evaluate its monoclonal antibodies against ovarian cancer cells as diagnostic reagents.
One of the largest and longest-running efforts to evaluate the potential benefits of the Mediterranean-style diet in lowering risk of stroke found that the diet may be especially protective in women over 40 regardless of menopausal status or hormone replacement therapy, according to new research in the American Heart Association's journal Stroke.
Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp, announced today it has received U.S. Food and Drug Administration (FDA) clearance to market Zargis Acoustic Cardioscan (Cardioscan), the first and only computer-aided medical device to support physicians in analyzing heart sounds for the identification of suspected murmurs, a potential sign of heart disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Candice Joi Hunter, MD Po Box 1000, Dyer, IN 46311-0800 Ph: (219) 864-2107 | Candice Joi Hunter, MD 24 Joliet St, Dyer, IN 46311-1705 Ph: (219) 322-5747 |
News Archive
Researchers who analyzed payroll-based staffing data for U.S. nursing homes discovered large daily staffing fluctuations, low weekend staffing and daily staffing levels that often fall well below the expectations of the Centers for Medicare and Medicaid Services, all of which can increase the risk of adverse events for residents.
MabCure Inc., a leading developer of antibody-based technology for the diagnosis and treatment of ovarian, prostate, colorectal and other cancers, has retained the CUNY Center for Advanced Technology (CUNY CAT) to evaluate its monoclonal antibodies against ovarian cancer cells as diagnostic reagents.
One of the largest and longest-running efforts to evaluate the potential benefits of the Mediterranean-style diet in lowering risk of stroke found that the diet may be especially protective in women over 40 regardless of menopausal status or hormone replacement therapy, according to new research in the American Heart Association's journal Stroke.
Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp, announced today it has received U.S. Food and Drug Administration (FDA) clearance to market Zargis Acoustic Cardioscan (Cardioscan), the first and only computer-aided medical device to support physicians in analyzing heart sounds for the identification of suspected murmurs, a potential sign of heart disease.
› Verified 2 days ago
Rodney J.s. Deaton, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 24 Joliet St, Dyer, IN 46311 Phone: 219-865-2141 Fax: 219-864-2147 | |
Christopher Francis Shahzaad, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 24 Joliet St, Dyer, IN 46311 Phone: 219-322-5747 Fax: 219-864-2282 | |
Chao Gong, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 24 Joliet St, Dyer, IN 46311 Phone: 219-865-2141 Fax: 219-852-2502 | |
Shahnour Yaylayan, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 24 Joliet St, Dyer, IN 46311 Phone: 219-322-5747 Fax: 219-864-2282 | |
Dr. Cyrus D Solhkhah, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 24 Joliet St, Dyer, IN 46311 Phone: 219-322-5747 | |
Dr. Abdullah Tolaymat, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2111 Northwinds Dr, Dyer, IN 46311 Phone: 219-836-2096 Fax: 219-319-0647 | |
Natasha Clark, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 24 Joliet St, Dyer, IN 46311 Phone: 317-322-5747 Fax: 219-864-2282 |